BofA/Merrill Lynch Double Downgrades Teva Pharma (TEVA) to Underperform
Tweet Send to a Friend
(Updated - May 30, 2019 6:21 AM EDT)(updated to add price target and analyst comments)BofA/Merrill Lynch analyst Jason Gerberry downgraded ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
